NCT06776874 Observational Study to Develop a Predictive Score for Adverse Events Post ERCP
| NCT ID | NCT06776874 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Endoscopic Retrograde Cholangiopancreatography |
| Study Type | OBSERVATIONAL |
| Enrollment | 981 participants |
| Start Date | 2021-03-24 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 981 participants in total. It began in 2021-03-24 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main objective of the study is: the identification of independent factors associated with an increased risk of post-ERCP complications. Other objectives are: the development of a predictive model of events post-ERCP adverse events and its validation; geographic validation of a predictive model already published in the literature using data collected during the study and the evaluation of the rate of post-ERCP AEs in the centers involved in the study.
Eligibility Criteria
Inclusion Criteria: * Age \>18 years * Patients admitted with hepato-biliary-pancreatic disease or other pathological conditions that require treatment by ERCP * Obtaining informed consent Exclusion Criteria: * None
Contact & Investigator
Lorenzo Lorenzo, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06776874 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Endoscopic Retrograde Cholangiopancreatography. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06776874 currently recruiting?
Yes, NCT06776874 is actively recruiting participants. Contact the research team at lorenzo.fuccio@aosp.bo.it for enrollment information.
Where is the NCT06776874 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06776874 clinical trial?
NCT06776874 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Lorenzo Lorenzo, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 981 participants.